Αρχική World News Brain Cancer Cells Hijack Gene “On Switches” to Drive Tumor Growth

Brain Cancer Cells Hijack Gene “On Switches” to Drive Tumor Growth

, by NCI Staff

A microscopy image showing amplified EGFR in DNA circles that are separate from chromosomes.

Glioblastoma cells have normal x-shaped chromosomes (blue) with areas where the oncogene EGFR is found (green), but also circular pieces of DNA (red) with many additional copies of EGFR.

Credit: Megan Piazza, Ph.D., Case Western Reserve University

Cancer cells go to great lengths to sustain their growth, survival, and spread. Now scientists believe they have uncovered yet another way in which cancer cells may support their own uncontrolled growth.

The discovery emerged from a study of brain cancer cells, which are known to sneak multiple copies of an oncogene into circular pieces of DNA that are separate from chromosomes. In the new NCI-funded study, scientists found that brain cancer cells also slip several different genetic “on switches”—pieces of DNA that help activate genes—into these DNA circles. 

The on switches (also called enhancers or regulatory elements) activated the copied oncogene and were critical for driving the cancer’s growth, the researchers found. 

The findings, published November 27 in Cell, support a different way of thinking about cancer, said Peter Scacheri, Ph.D., of Case Western Reserve University. 

“We think it’s not just the oncogene that is the driver [of cancer], it’s the oncogene plus regulatory elements,” he explained.

Many current cancer treatments target altered proteins produced by key oncogenes. But, in light of the new findings, “we are thinking about how we can target all this extra DNA that’s important on these circles,” Dr. Scacheri said. “We are thinking about how to exploit this new knowledge for therapies.” 

Extra Copies of Oncogenes

About 40 years ago, scientists noticed that some cancer cells repeatedly copy and paste —sometimes upwards of 50 times—the same oncogene in their DNA. This phenomenon, called oncogene amplification, is common in certain types of cancer. 

For example, in an aggressive type of brain cancer called glioblastoma, tumor cells typically have many copies of the EGFR oncogene.

Many scientists thought that simply having several copies of an oncogene could cause a cell to become cancerous, explained Ian Fingerman, Ph.D., of the DNA and Chromosome Aberrations Branch in NCI’s Division of Cancer Biology, who wasn’t involved in the study.

But that “is a very ‘gene-centric’ view,” he said. A gene is a section of DNA that contains information for making a protein.  

Instead of looking at genes, Dr. Scacheri and his colleagues wanted to know if other sections of DNA, like regulatory elements, were amplified along with EGFR in glioblastoma. 

First, the team looked for patterns in the DNA surrounding amplified EGFR in 174 samples from glioblastoma tumors. It turned out that almost every tumor contained the same two switches alongside EGFR. These switches also activate EGFR in cells that lack amplification of the gene, they found. 

“When genes get amplified, it looks like they are scooping up regulatory elements that are controlling their expression,” Dr. Scacheri said.

It’s surprising that “specific enhancers are consistently co-amplified with the oncogene,” said Dr. Fingerman. It suggests that, over time, certain enhancers may become amplified because they provide an advantage to cancer cells, he added.

A Variety of On Switches

Further experiments identified a variety of additional on switches near amplified EGFR in several glioblastoma samples. Unlike the other two switches, these elements are typically isolated from EGFR on the chromosome and don’t normally activate the gene. 

In some of the glioblastoma samples, the amplified EGFR and accompanying on switches were found in DNA circles that were separate from chromosomes.

Moreover, the switches appeared to be vital to glioblastoma cells. When the scientists used DNA editing techniques to interfere with each of the switches individually, EGFR gene expression and cell survival dropped. 

“It’s possible that, in DNA circles, contacts between genes and enhancers that normally would have been prevented in the chromosome are driving cancer cell growth via additional boosts to gene expression,” Dr. Fingerman noted.

In some glioblastoma cells, there were more copies of on switches than copies of EGFR. The researchers believe that the number and variety of switches are optimized to help the cancer cells survive and grow, Dr. Scacheri explained. 

What’s more, amplification of normally distant switches with oncogenes may be a more general phenomenon beyond just glioblastoma. The researchers noticed a similar pattern of amplification in samples of nine different types of cancer, including medulloblastoma, neuroblastoma, and Wilms tumor

Many of the cancers that have this pattern are aggressive cancers that are difficult to treat, Dr. Scacheri pointed out.

Mysterious DNA Circles 

Although researchers have known for more than 50 years that DNA circles—also called extrachromosomal DNA—are common in cancer cells, there are still many questions about how they form and what their purpose is.

One idea is that they are created when a chromosome is shattered and put back together—an event known as chromothripsis. This possibility could explain how switches from distant parts of the chromosome ended up in DNA circles with EGFR, the researchers wrote.

It also hasn’t been clear what genetic information is contained in DNA circles, but new technologies have allowed researchers to take a closer look, Dr. Scacheri explained. 

“We assumed that [DNA circles] just carried oncogenes and that everything else was junk. But it turns out that most of that extra DNA is important,” he added.

For cancer cells, there may be advantages to having many copies of an oncogene and on switches in small DNA circles rather than in a large, tightly packed chromosome, Dr. Scacheri explained.

For instance, another recent study showed that genes in DNA circles are more easily activated than genes located in chromosomes, potentially giving cancer cells an easier way to increase oncogene expression. 

DNA circles may also make cancer cells more adaptive in response to stress such as cancer treatment, Dr. Scacheri suggested. In fact, a 2013 study showed that in glioblastoma cells, the number of EGFR copies in DNA circles can go up and down to help the cells resist the effects of drugs that block EGFR

In addition, not all cancer cells in a tumor have the same number of DNA circles, Dr. Fingerman pointed out. That diversity may affect the tumor’s response to treatment, he said.

Dr. Scacheri and his colleagues plan to investigate DNA circles further and hope to find a way to target the many on switches they carry.

Because on switches work by activating gene transcription, treatments that target aspects of transcription, such as a class of drugs known as histone deacetylase inhibitors, could also be an avenue for exploration, Dr. Fingerman said. 



Συμπληρώστε το email σας για να λαμβάνετε τις σημαντικότερες ειδήσεις από το ogkologos.com

Βρείτε μας

2,449ΥποστηρικτέςΚάντε Like

Διαβαστε Επίσης

Καρκίνος και Κορωνοϊός (COVID-19) ΜΕΡΟΣ Α

Εάν είστε καρκινοπαθής, το ανοσοποιητικό σας σύστημα μπορεί να μην είναι τόσο ισχυρό όσο κανονικά, έτσι μπορεί να ανησυχείτε για τους κινδύνους που σχετίζονται...


Η Παγκόσμια Ημέρα Κατά του Καρκίνου καθιερώθηκε με πρωτοβουλία της Διεθνούς Ένωσης κατά του Καρκίνου (UICC), που εκπροσωπεί 800 οργανώσεις σε 155 χώρες του...


ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ) Γράφει ο Δρ Παπαδούρης Σάββας, Παθόλογος-Ογκολόγος   Ο ΜΜΚΠ βρίσκεται αναλογικά στο 80% και πλέον του συνολικού...

Διατρέχουν όντως οι καρκινοπαθείς μεγαλύτερο κίνδυνο λόγω κοροναϊού;

Σε πρακτικό επίπεδο, τα δεδομένα των σχετικών μελετών υποδηλώνουν ότι η χημειοθεραπεία ή οι άλλες αντι-νεοπλασματικές θεραπείες δεν αυξάνουν σημαντικά τον κίνδυνο θνησιμότητας από...

FDA: Η ακτινοβολία των smartphones δεν προκαλεί καρκίνο

Σε μια νέα έκθεσή της, η Υπηρεσία Τροφίμων και Φαρμάκων (FDA) των ΗΠΑ αναφέρει ότι επανεξέτασε τις σχετικές επιστημονικές έρευνες που δημοσιεύθηκαν τα τελευταία...

Νέα ανακάλυψη, νέα ελπίδα για τον καρκίνο

Ένα νεοανακαλυφθέν τμήμα του ανοσοποιητικού μας συστήματος θα μπορούσε να αξιοποιηθεί για την αντιμετώπιση όλων των ειδών καρκίνου, σύμφωνα με επιστήμονες του πανεπιστημίου Cardiff...
- Advertisment -

Ροή Ειδήσεων

FDA Approves Pembrolizumab Combination for the First-Line Treatment of Cervical Cancer

On 13 October 2021, the US Food and Drug Administration (FDA) approved pembrolizumab (Keytruda, Merck) in combination with chemotherapy, with or without bevacizumab, for...

From Scan to Scan: The Challenges of Living with Metastatic Cancer

October 15, 2021, by NCI Staff Bethany Ross has been living with metastatic neuroendocrine cancer since she was diagnosed in 2018. Credit: Used with permission from...

The award-winning researcher behind next generation sequencing

Next generation sequencing (NGS) has given the genomic research community ultra-high throughput, scalability, and speed that could only be dreamed of 20 years ago....

Many Breast Cancer Patients Use Cannabis to Manage Symptoms But Don’t Tell Their Doctors

Cancer and cancer treatment come with many side effects, including nausea, vomiting, and pain. In addition to the physical toll, the impacts to a...

Medicare Open Enrollment Starts Tomorrow!

Medicare open enrollment is upon us for 2022. If you are a Medicare recipient, this is the time of year when you can make...

Cancer in My Community: Providing Supportive Care in Serbia

Cancer in My Community is a Cancer.Net Blog series that shows the global impact of cancer and how people work to care for those with...